Abstract
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.
Michiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, Jan Meijerink, Piet L C M van Riel, Joanneke in't Hout and Leo B A van de Putte
The Journal of Rheumatology September 2006, 33 (9) 1726-1733;
Michiel M Zandbelt
Jos G A Houbiers
Frank H J van den Hoogen
Jan Meijerink
Piet L C M van Riel
Joanneke in't Hout
In this issue
The Journal of Rheumatology
Vol. 33, Issue 9
1 Sep 2006
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.
Michiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, Jan Meijerink, Piet L C M van Riel, Joanneke in't Hout, Leo B A van de Putte
The Journal of Rheumatology Sep 2006, 33 (9) 1726-1733;
Intranasal administration of recombinant human cartilage glycoprotein-39. A phase I escalating cohort study in patients with rheumatoid arthritis.
Michiel M Zandbelt, Jos G A Houbiers, Frank H J van den Hoogen, Jan Meijerink, Piet L C M van Riel, Joanneke in't Hout, Leo B A van de Putte
The Journal of Rheumatology Sep 2006, 33 (9) 1726-1733;